Diffuse goitre enlargement after immunotherapy for non‐small cell lung cancer
Key message It is well known that a phenomenon called hyperprogressive disease (HPD) often occurs during immunotherapy with immune checkpoint inhibitors. In the present case, we experienced a case of HPD in a potential metastatic thyroid tumour during immunotherapy. HPD can be life‐threatening depen...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-11-01
|
| Series: | Respirology Case Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/rcr2.866 |
| _version_ | 1819145410392883200 |
|---|---|
| author | Kohei Fujita Norio Araki Tadashi Mio |
| author_facet | Kohei Fujita Norio Araki Tadashi Mio |
| author_sort | Kohei Fujita |
| collection | DOAJ |
| description | Key message It is well known that a phenomenon called hyperprogressive disease (HPD) often occurs during immunotherapy with immune checkpoint inhibitors. In the present case, we experienced a case of HPD in a potential metastatic thyroid tumour during immunotherapy. HPD can be life‐threatening depending on where it appears, so clinicians need to be careful. |
| first_indexed | 2024-12-22T12:57:35Z |
| format | Article |
| id | doaj.art-91bd4882bd144a8896ce97d84a0914b0 |
| institution | Directory Open Access Journal |
| issn | 2051-3380 |
| language | English |
| last_indexed | 2024-12-22T12:57:35Z |
| publishDate | 2021-11-01 |
| publisher | Wiley |
| record_format | Article |
| series | Respirology Case Reports |
| spelling | doaj.art-91bd4882bd144a8896ce97d84a0914b02022-12-21T18:25:05ZengWileyRespirology Case Reports2051-33802021-11-01911n/an/a10.1002/rcr2.866Diffuse goitre enlargement after immunotherapy for non‐small cell lung cancerKohei Fujita0Norio Araki1Tadashi Mio2Division of Respiratory Medicine, Center for Respiratory Diseases National Hospital Organization Kyoto Medical Center Kyoto JapanDepartment of Radiation Oncology National Hospital Organization Kyoto Medical Center Kyoto JapanDivision of Respiratory Medicine, Center for Respiratory Diseases National Hospital Organization Kyoto Medical Center Kyoto JapanKey message It is well known that a phenomenon called hyperprogressive disease (HPD) often occurs during immunotherapy with immune checkpoint inhibitors. In the present case, we experienced a case of HPD in a potential metastatic thyroid tumour during immunotherapy. HPD can be life‐threatening depending on where it appears, so clinicians need to be careful.https://doi.org/10.1002/rcr2.866goitre enlargementimmunotherapynivolumabPD‐1thyroid |
| spellingShingle | Kohei Fujita Norio Araki Tadashi Mio Diffuse goitre enlargement after immunotherapy for non‐small cell lung cancer Respirology Case Reports goitre enlargement immunotherapy nivolumab PD‐1 thyroid |
| title | Diffuse goitre enlargement after immunotherapy for non‐small cell lung cancer |
| title_full | Diffuse goitre enlargement after immunotherapy for non‐small cell lung cancer |
| title_fullStr | Diffuse goitre enlargement after immunotherapy for non‐small cell lung cancer |
| title_full_unstemmed | Diffuse goitre enlargement after immunotherapy for non‐small cell lung cancer |
| title_short | Diffuse goitre enlargement after immunotherapy for non‐small cell lung cancer |
| title_sort | diffuse goitre enlargement after immunotherapy for non small cell lung cancer |
| topic | goitre enlargement immunotherapy nivolumab PD‐1 thyroid |
| url | https://doi.org/10.1002/rcr2.866 |
| work_keys_str_mv | AT koheifujita diffusegoitreenlargementafterimmunotherapyfornonsmallcelllungcancer AT norioaraki diffusegoitreenlargementafterimmunotherapyfornonsmallcelllungcancer AT tadashimio diffusegoitreenlargementafterimmunotherapyfornonsmallcelllungcancer |